Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories
- 16 Downloads
In 1984 the European Study Group on Antibiotic Resistance (ESGAR) consecutively collected gram-negative bacilli and staphylococci blood isolates and performed susceptibility testing with 11 antibiotics using the microdilution method. In all 2,578 isolates were collected: 68% gram-negative bacilli and 32% staphylococci. The MICs of ampicillin and cefazoline for the susceptible gram-negative bacilli were 1–8μg/ml; of piperacillin⩽0.5–4; of Sch 34343, cefotaxime, moxalactam, ceftazidime and aztreonam⩽0.5–2μg/ml; of cefoxitin, cefuroxime and cefamandole⩽0.5–8μg/ml. For susceptible staphylococci the MICs of cefazoline and cefuroxime were⩽0.5–1μg/ml, and of cefoxitin, moxalactam, ceftazidime and cefotaxime,⩽0.5–32 μg/ml. The resistance levels varied between laboratories and countries, being lower in Northern Europe. In clinical protocols on patients with gram-negative septicemia from whom cefazoline-resistant strains were isolated, cefotaxime was the beta-lactam most commonly used (12%). In protocols on patients with staphylococcal septicemia from whom gentamicin-resistant or cefazoline-resistant strains were isolated, the most commonly used beta-lactam was cloxacillin (6%).
KeywordsCefotaxime Ceftazidime Cefuroxime Cefazoline Piperacillin
Unable to display preview. Download preview PDF.
- 3.The Swedish Reference Group for Antibiotics: A revised system for antibiotic sensitivity testing. Scandinavian Journal of Infectious Diseases 1981, 13: 148–152.Google Scholar
- 7.Dornbusch, K., Bengtsson, S., Bernander, S., Brorson, J. E., Forsgren, A., Holm, S., Malmborg, A. S., Nilsson, L., Mittermayer, H., Breitfellner, G., Rotter, M., Thiel, W., Mouton, R. P., Renkonen, O. V.: In vitro susceptibility to four aminoglycoside antibiotics among blood isolates from laboratories in four countries. Proceedings of 13th ICC, Vienna 1983, p. 87/50.Google Scholar
- 9.Ljungman, P., Malmborg, A. S., Nyström, B., Tillegård, A.: Bacteremia in a Swedish University Hospital. A oneyear prospective study in 1981 and a comparison with 1975–76. Infection 1984, 2–6.Google Scholar
- 13.Wise, R., Phillips, I. (ed.): Sch 34343 — a new parenteral penem. Journal of Antimicrobial Chemotherapy 1985, 15, Supplement C: 1–238.Google Scholar
- 14.Norrby, R., Bergan, T., Holm, S., Normark, S. (ed.): Evaluation of new beta-lactam antibiotics. Reviews of Infectious Diseases 1986, 8, Supplement 3: S235–S370.Google Scholar
- 16.Kurpis, L., Schaberg, D., Fekety, R.: In-vitro activity of Sch 34343 against nosocomial pathogens: methicillin-resistant staphylococci, gentamicin-susceptible and -resistantStreptococcus faecalis, Clostridium difficile andBacteroides fragilis, Journal of Antimicrobial Chemotherapy 1985, 15, Supplement C: 133–136.PubMedGoogle Scholar
- 17.Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Report of an International Collaborative study. Acta Pathologica et Microbiologica Scandinavia (B) 1971, Supplement 217: 1–90.Google Scholar
- 18.European Study Group on Antibiotic Resistance: In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in 29 European laboratories. European Journal of Clinical Microbiology 1987, 6: 378–385.Google Scholar